)
Investor Relations14 Oct 2025
Boost Your Earnings Season Strategy With Real‑Time Alerts
Quartr Pro provides real time alerts, trend analysis and live coverage, giving analysts and investors instant insights to act faster in earnings.
Ipca Laboratories (IPCALAB) investor relations material
Ipca Laboratories Q1 25/26 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 25/26 earnings summary12 Aug, 2025
Executive summary
Domestic business grew 10% in Q1 FY26, outpacing the market, with improved market share and strong performance in acute and chronic segments.
Export branded formulation business grew 10% year-over-year; generic business up 15%, and API business up 12%, driven by strong performance in Europe and Latin America.
Standalone net profit increased 28% to ₹262 crore; consolidated net profit rose 18% to ₹234 crore compared to Q1 FY25.
Standalone net total income rose 12% year-over-year to ₹1,771.92 crore; consolidated net total income increased 11% to ₹2,341.51 crore.
Indian formulations income increased 10% to ₹961.01 crore; export income surged 18% to ₹699.76 crore.
Financial highlights
Standalone EBITDA margin improved to 23.82% from 22.22% in Q1 FY25; consolidated EBITDA margin slightly declined to 18.39% from 18.52%.
Standalone gross margin reached 74%, attributed to favorable product mix and higher-margin therapy growth.
Standalone EPS rose to ₹10.33 from ₹8.05; consolidated EPS increased to ₹9.19 from ₹7.58 year-over-year.
Standalone revenue from operations reached ₹1,746.90 crore, up from ₹1,565.86 crore; consolidated revenue from operations was ₹2,308.85 crore, up from ₹2,092.63 crore.
Standalone net profit after tax was ₹262.04 crore, up from ₹204.13 crore; consolidated net profit after tax was ₹233.21 crore, up from ₹192.24 crore.
Outlook and guidance
Full-year revenue growth guidance maintained at 9–10%; consolidated EBITDA margin guidance revised to a 75 bps increase (from 100 bps) due to lower Unichem margins.
Unichem EBITDA target of ₹300 crore for FY26 unlikely to be met; improvement expected in subsequent quarters.
Domestic margin expansion expected to continue, supported by productivity gains and recent workforce additions.
Management highlighted continued growth in both domestic and export markets, with a focus on expanding branded and generic formulations.
Unichem Q1 margin decline: key drivers?
Subsidiaries' profitability timeline?
Ipca standalone US business scaling plan?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Ipca Laboratories earnings date
Q2 25/2611 Nov, 2025
Next Ipca Laboratories earnings date
Q2 25/2611 Nov, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Edge3 Oct 2025
Epiroc: A Culture of Moving Mountains
From automation to electrification, Swedish industrial giant Epiroc is leading a transformation in how the world mines.
)
Company Research22 Sep 2025
Moody's: Shaping Global Credit
Explore Moody's evolution from publishing manuals to becoming a giant in credit ratings, guiding issuers, investors, and regulators worldwide.
Frequently asked questions
Ipca Laboratories Limited is an India-based pharmaceutical company engaged in the manufacturing and marketing of active pharmaceutical ingredients and finished dosage forms. The company’s products cover therapeutic segments such as pain management, cardiovascular, anti-malarial, anti-infective, and dermatology. Ipca serves domestic and international markets, supplying to both branded and generic sectors, and also operates in the institutional supply segment. The company is headquartered in Mumbai, India, and its shares are listed on the BSE.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage